Journal of Neuroscience study examines medicinal properties of cannabis
OHSU research suggests an avenue for developing treatments for chronic pain that harness the medicinal properties of cannabis while minimizing the threat of addiction.
The study, conducted in a rodent model, provides additional rationale for the development of therapeutics using cannabinoid receptors to treat chronic pain, which afflicts about 30 percent of the U.S. population. OHSU investigators studied the function of two forms of cell membrane receptors that bind cannabinoids that occur naturally within the body, called endocannabinoids.
“It may be an avenue where we can get better pain medications that are not addictive,” said senior author Susan Ingram, Ph.D., an associate professor of neurosurgery in the OHSU School of Medicine.
Ingram and colleagues report the treatment of chronic pain has challenged the medical system, with medications that are ineffective or create serious side effects: “However, emerging data indicate that drugs that target the endocannabinoid system might produce analgesia with fewer side effects compared with opioids.”
The body’s endocannabinoid system comprises receptors, endocannabinoid molecules and enzymes that make and degrade the endocannabinoids located in the brain and throughout the central and peripheral nervous system. The research team focused on two cannabinoid receptors, known as CB1 and CB2, in the rostral ventromedial medulla – a group of neurons located in the brainstem known to modulate pain. The study is the first to examine CB1 and CB2 receptor function at the membrane level in late adolescent and adult neurons.
The researchers observed that chronic inflammatory pain increased activity of CB2 receptors and decreased CB1 activity. Cannabis activates both CB1 and CB2 receptors equally. The study suggests that selective activation of CB2 receptors contributes to the medicinal benefit of cannabis while minimizing the propensity of the other cannabinoid receptor, CB1, to induce tolerance and withdrawal. Ingram said the next phase of the research will further explore this area of brain circuitry, which ultimately could lead to the development of a new class of pain medications.
Learn more: Scientists reveal non-addictive pathway to pain relief
[osd_subscribe categories=’pain’ placeholder=’Email Address’ button_text=’Subscribe Now for any new posts on the topic “PAIN”‘]
Receive an email update when we add a new PAIN article.
The Latest on: Non-addictive pain relief
[google_news title=”” keyword=”non-addictive pain relief” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Non-addictive pain relief
- Painful Truth Campaign encourages non-opioid solutions for pain reliefon April 24, 2024 at 6:20 pm
The United States makes up around 4% of the world's population, but it consumes more than 80% of the world's opioids.
- Vertex’s stock climbs as non-opioid pain treatment advanceson April 18, 2024 at 5:59 am
Vertex Pharmaceuticals shares gained ground early Thursday after the company signaled progress in the development of its experimental non-opioid pain treatment.
- Vertex's stock climbs as non-opioid pain treatment advanceson April 17, 2024 at 10:59 pm
Biotech company signals progress in closely watched effort to develop non-addictive painkillers ... development of its experimental non-opioid pain treatment. The Boston-based biotech company ...
- Vertex Pharma scientist talks about the long road to developing non-addictive painkillerson April 15, 2024 at 2:24 pm
Patients suffering from pain have limited options when it comes to medication. For decades, the only two choices have been over-the-counter medicines like Tylenol or powerful prescription opioids.
- Vertex Pharma scientist talks about the long road to developing non-addictive painkillerson April 15, 2024 at 2:00 am
Vertex Pharmaceuticals recently reported positive results for a non ... well as addictive potential. Identifying additional medicines that could be used for people who need more pain relief ...
- Non-addictive options to Opioids: Exploring Pain Relief Options Before Taking Opioidson April 5, 2024 at 3:39 am
“The Painful Truth,” a new campaign by Mothers Against Prescription Drug Abuse in partnership with Aleve®, to encourage consumers to explore pain relief options before taking opioid ...
via Bing News